Literature DB >> 33001589

Additive manufacturing technologies enabling rapid and interventional production of protective face shields and masks during the COVID-19 pandemic.

Jędrzej Wierzbicki1, Maciej Nowacki1, Marta Chrzanowska1, Rafał Matkowski2,3, Marcin Ziętek2,3, Katarzyna Nowacka4, Adam Maciejczyk2,3, Edyta Pawlak-Adamska5.   

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is transmitted through respiratory droplets and contact routes, hence the demand for personal protective equipment (PPE) has increased during the outbreak of coronavirus disease 2019 (COVID-19). Among the most noticeable shortages was the lack of face shields. The urgent demand for PPE induced interdisciplinary cooperation to overcome the shortages, and additive manufacturing proved to be ideal for the crisis situation.
OBJECTIVES: To investigate the possibilities of implementing additive manufacturing technologies in the interventional fabrication of protective face shields for medical staff.
MATERIAL AND METHODS: An Ender 3 Pro 3D printer was used to print headbands and Cura 4.4 was chosen as the slicing software. Open source face shield designs were downloaded as standard tessellation language (STL) files and compared. Only models with scientific support were taken under consideration.
RESULTS: The mean time for producing the headbands tested ranged from 59 min to almost 3 h, depending on the design. After setting up our low budget printer and choosing the Prusa RC 3 protective face shield as the main product, we were able to fabricate about 30 face shields per week at a cost of about €1 each. During 4 weeks, 126 face shields were produced and delivered to various hospital wards, which substantially eased the shortages.
CONCLUSIONS: Additive manufacturing enables immediate responses to needs in emergency situations, and allows for mass production of personal protective equipment in a short time due the rapid exchange of data among printer users. Despite the unregulated legal situation and insufficient scientific evidence, such protective equipment has been approved by clinicians and is currently used by medical personnel around the world.

Entities:  

Keywords:  3-dimensional printing; COVID-19; additive manufacturing; face shield; personal protective equipment

Mesh:

Year:  2020        PMID: 33001589     DOI: 10.17219/acem/126296

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  6 in total

1.  Blockchain-Based Decentralized Digital Manufacturing and Supply for COVID-19 Medical Devices and Supplies.

Authors:  Walaa Alkhader; Khaled Salah; Andrei Sleptchenko; Raja Jayaraman; Ibrar Yaqoob; Mohammed Omar
Journal:  IEEE Access       Date:  2021-10-05       Impact factor: 3.367

Review 2.  Novel additive manufacturing applications for communicable disease prevention and control: focus on recent COVID-19 pandemic.

Authors:  Orcun Guvener; Abdullah Eyidogan; Cagdas Oto; Pinar Yilgor Huri
Journal:  Emergent Mater       Date:  2021-02-10

3.  3D Printed N-95 Masks During the COVID-19 Pandemic: Lessons Learned.

Authors:  Carole S L Spake; Thomas N Carruthers; Joseph W Crozier; Loree K Kalliainen; Reena A Bhatt; Scott T Schmidt; Albert S Woo
Journal:  Ann Biomed Eng       Date:  2021-09-03       Impact factor: 3.934

4.  The report and analysis concerning the usefulness of basic telemedicine tools in the skin cancer diagnostic screening process during COVID-19 pandemics.

Authors:  Marcin Ziętek; Maciej Nowacki; Jędrzej Wierzbicki; Rafał Matkowski; Adam Maciejczyk; Rafał Czajkowski; Edyta Pawlak-Adamska
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

5.  Community-driven PPE production using additive manufacturing during the COVID-19 pandemic: Survey and lessons learned.

Authors:  Hannah D Budinoff; Jannatul Bushra; Mohammed Shafae
Journal:  J Manuf Syst       Date:  2021-07-13       Impact factor: 8.633

Review 6.  3D Printing in Eye Care.

Authors:  Ryan D Larochelle; Scott E Mann; Cristos Ifantides
Journal:  Ophthalmol Ther       Date:  2021-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.